GlassScriptPhysician profile
Howard M Topley
NPI 1669586871
$433.82
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.21 · 2020: $16.25 · 2022: $220 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $103.59 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $49.51 | 2022 | |
| Medtronic USA, INC. | $37.73 | 2019 | |
| Olympus America INC. | $36.39 | 2019-2022 | |
| Janssen Biotech, INC. | $33.00 | 2024 | Akeega, Balversa, Erleada |
| Pfizer INC. | $30.41 | 2022 | |
| Amgen INC. | $20.92 | 2024 | Evenity, Prolia |
| Abbvie INC. | $20.31 | 2024 | |
| Coloplast Corp | $18.61 | 2024 | |
| Urovant Sciences INC | $18.35 | 2022 | |
| Travere Therapeutics, INC. | $16.75 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.70 | 2024 | Camzyos |
| Antares Pharma, INC. | $16.63 | 2024 | Xyosted |
| Kowa Pharmaceuticals America, INC. | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Topley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.